Alkyl Amines Chemicals profit and loss

Latest FY26

Revenue: ₹1,536cr−2.3% on FY25
EBITDA: ₹285cr−2.2% on FY25
Net profit: ₹180cr−3.3% on FY25
EPS: ₹35.20−3.3% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Expenses
	1,658	1,536	1,572	1,441	1,682	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	33.0	31.7	29.8	15.1	13.9
	1,691	1,568	1,602	1,456	1,696
	889	791	834	775	856
	−21.2	28.4	4.4	−7.6	3.7
	119	110	104	95.2	97.6
	1.3	1.2	1.0	4.4	3.3
	71.6	71.7	71.2	58.9	45.2
	330	322	338	327	382
	1,390	1,324	1,353	1,253	1,388
	342	285	291	251	343
	270	213	220	192	298
Profit
	302	243	249	202	309
	302	243	249	202	309
	67.5	53.1	47.8	35.4	71.1
	9.1	10.4	14.8	18.2	8.8
	76.6	63.5	62.5	53.6	79.9
	225	180	186	149	229
	225	180	186	149	229
	−0.0	−0.1	−1.4	−1.5	−1.9
	225	180	185	147	227
Per share
	₹44.03	₹35.20	₹36.40	₹29.13	₹44.75
	₹43.96	₹35.15	₹36.25	₹29.09	₹44.68
Revenue detail — as filed
	—	−1.4	0.0	0.0	0.0
Other comprehensive income — detail
	−0.0	−0.1	−1.4	—	—
	−0.5	0.6	−1.5	−2.0	−2.3
	−1.1	0.2	−0.4	—	—
	—	—	—	−0.5	−0.6
	—	−0.4	−0.4	0.0	−0.2
	0.1	0.1	−0.1	—	—
	—	—	—	0.0	−0.1
Per share — as-filed variants
	₹44.03	₹35.20	₹36.40	₹29.13	₹44.75
	₹43.96	₹35.15	₹36.25	₹29.09	₹44.68
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	791	717	733	673	823
	47.7%	46.7%	46.6%	46.7%	48.9%
Adjusted (ex-exceptional items) — derived
	302	243	249	202	309
	225	180	186	149	229
	₹44.03	₹35.20	₹36.40	₹29.13	₹44.75

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

ALKYLAMINE₹1,653.80

Alkyl Amines Chemicals Ltd.

· Chemicals

Annual Quarterly₹ CrorePeersBALAMINES AETHER ACI TECILCHEM ELLEN GHCL GNFC GSFCMcap ₹8,459 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Revenue from Operations	1,682.3	1,440.6	1,571.8	1,535.9	1,658.3
Other Income	13.9	15.1	29.8	31.7	33.0
Total Income	1,696.2	1,455.7	1,601.6	1,567.5	1,691.3
Expenses
+ Cost of Materials Consumed	856.0	775.2	834.4	790.9	888.7
+ Changes in Inventories	3.7	-7.6	4.4	28.4	-21.2
+ Employee Benefit Expense	97.6	95.2	103.6	110.2	119.2
+ Finance Costs	3.3	4.4	1.0	1.2	1.3
+ Depreciation & Amortisation	45.2	58.9	71.2	71.7	71.6
+ Other Expenses	381.9	327.2	338.4	321.8	330.0
Total Expenses	1,387.7	1,253.2	1,353.0	1,324.0	1,389.5
EBITDA	343.1	250.7	291.1	284.6	341.7
EBIT	298.0	191.8	219.9	213.0	270.1
Profit
PBT before Exceptional Items	308.6	202.5	248.6	243.5	301.8
Pretax Income	308.6	202.5	248.6	243.5	301.8
+ Current Tax	71.1	35.4	47.8	53.1	67.5
+ Deferred Tax	8.8	18.2	14.8	10.4	9.1
Tax Expense	79.9	53.6	62.5	63.5	76.6
Net Income	228.7	148.9	186.1	180.0	225.2
+ Net Income — Continuing Ops	228.7	148.9	186.1	180.0	225.2
+ Other Comprehensive Income	-1.9	-1.5	-1.4	-0.1	-0.0
Total Comprehensive Income	226.8	147.4	184.7	179.9	225.2
Per Share
Basic EPS	44.75	29.13	36.40	35.20	44.03
Diluted EPS	44.68	29.09	36.25	35.15	43.96
Revenue Detail — as filed
+ Share of P&L — Partnership Firms / LLPs	0.0	0.0	0.0	-1.4	—
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	-1.4	-0.1	-0.0
+ Items NOT to be Reclassified to P&L	-2.3	-2.0	-1.5	0.6	-0.5
+ Tax on Items NOT to be Reclassified	—	—	-0.4	0.2	-1.1
+ Tax on Items NOT to be Reclassified — alt tag	-0.6	-0.5	—	—	—
+ Items to be Reclassified to P&L	-0.2	0.0	-0.4	-0.4	—
+ Tax on Items to be Reclassified	—	—	-0.1	0.1	0.1
+ Tax on Items to be Reclassified — alt tag	-0.1	0.0	—	—	—
Per Share — as-filed variants
Basic EPS — Continuing Operations	44.75	29.13	36.40	35.20	44.03
Diluted EPS — Continuing Operations	44.68	29.09	36.25	35.15	43.96
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	822.7	673.1	733.0	716.6	790.8
Gross Margin %	48.90	46.72	46.64	46.65	47.69
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	308.6	202.5	248.6	243.5	301.8
Net Income Adj (tax-effected)	228.7	148.9	186.1	180.0	225.2
EPS Adj	44.75	29.13	36.40	35.20	44.03
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	2.00	2.00	2.00	2.00	2.00
Filed Dscr	—	—	251.33	103.88	205.32
Filed Iscr	—	—	247.47	177.20	318.70
Paid Up Equity Capital	10.2	10.2	10.2	10.2	10.2

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.